These emerging therapies, including Wegovy, a similar compound, and another option, represent a important advancement in treating type 2 the condition and supporting weight loss . They operate by emulating the body’s natural incretin GLP-1 , enabling to regulate blood glucose and decrease appetite . Every drug has slightly distinct properties and